Posts by: Marisa Wexler

News

The Polish Department of Registration of Medicinal Products (URPL) has granted Moleculin Biotech permission to accelerate the dose-escalation portion of a Phase 1/2 clinical trial of Annamycin, which is being ... Read more

January 24, 2020February 6, 2020

Computers Can Quickly See Patterns in Data to Diagnose Ills Like AML, Study Suggests

News

Using artificial intelligence to analyze gene expression patterns — which genes are ‘switched on’ — in blood cells could aid in the diagnosing acute myeloid leukemia (AML) more quickly, potentially ... Read more